BetterLife Pharma (BETRF) Shares Outstanding (2010 - 2026)

BetterLife Pharma's Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $154.4 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 18.7% year-over-year to $154.4 million; the TTM figure through Apr 2026 stood at $154.4 million (up 18.7% YoY), while the FY2026 annual figure was $151.9 million, up 4.4% from the prior year.
• Shares Outstanding (Entity) for Q2 2026 stood at $154.4 million, up from $151.9 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $154.4 million in Q2 2026, with the low at $75.4 million in Q2 2022.
• The 5-year median for Shares Outstanding (Entity) is $115.9 million (2024), against an average of $114.4 million.
• Peak annual rise in Shares Outstanding (Entity) reached 215.39% in 2022, while the deepest fall reached 0.34% in 2022.
• BetterLife Pharma's Shares Outstanding (Entity) stood at $85.9 million in 2022, then surged by 31.31% to $112.8 million in 2023, then climbed by 14.73% to $129.5 million in 2024, then climbed by 15.64% to $149.7 million in 2025, then increased by 3.15% to $154.4 million in 2026.
• Business Quant data shows BETRF's Shares Outstanding (Entity) at $154.4 million in Q2 2026, $151.9 million in Q1 2026, and $149.7 million in Q3 2025.